New chemotherapy treatments in advanced cancer patients: an easily applicable evaluation of clinical efficacy and cost-effectiveness.

about

Use of number needed to treat in cost-effectiveness analyses.Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer The combined effects of physical exercise training and detraining on adiponectin in overweight and obese children.

P2860

Q38086820-5194D3C4-5D37-4B7A-BC94-774394FF30C2 Q38905885-9903155F-822F-49C7-9CF5-00355FBD4971 Q53306165-A1CBB1E9-AE90-44D2-94CE-8F96C7D07446

P2860

New chemotherapy treatments in advanced cancer patients: an easily applicable evaluation of clinical efficacy and cost-effectiveness.

Item

http://www.wikidata.org/entity/Q35669545

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

New chemotherapy treatments in ...... ficacy and cost-effectiveness.

@ast

New chemotherapy treatments in ...... ficacy and cost-effectiveness.

@en

type

Item

label

New chemotherapy treatments in ...... ficacy and cost-effectiveness.

@ast

New chemotherapy treatments in ...... ficacy and cost-effectiveness.

@en

prefLabel

New chemotherapy treatments in ...... ficacy and cost-effectiveness.

@ast

New chemotherapy treatments in ...... ficacy and cost-effectiveness.

@en

P1476

New chemotherapy treatments in ...... ficacy and cost-effectiveness.

@en

P2093

Amalia Fernández Feijóo

http://www.w3.org/2001/XMLSchema#string

Eduardo Briones

http://www.w3.org/2001/XMLSchema#string

Jorge Hernández

http://www.w3.org/2001/XMLSchema#string

José Expósito

http://www.w3.org/2001/XMLSchema#string

Teresa Nieto

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

Key issues in the treatment of advanced breast cancer. Expectations and outcomes.

Efficacy, safety, and cost of new anticancer drugs.

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

Mature results from three large controlled studies with raltitrexed ('Tomudex').

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

Comparative efficiency of national health systems: cross national econometric analysis.

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.

P304

895-902

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/02841860310018981

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8164036

http://www.w3.org/2001/XMLSchema#string

P698

14968950

http://www.w3.org/2001/XMLSchema#string

New chemotherapy treatments in advanced cancer patients: an easily applicable evaluation of clinical efficacy and cost-effectiveness.

about

P2860

P2860

New chemotherapy treatments in advanced cancer patients: an easily applicable evaluation of clinical efficacy and cost-effectiveness.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698